Yatırımcı.AI

HGH vs KLS Fund Comparison

Price, period returns, size, investor count and risk score of HGH (Hedef Portföy Güneş Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) and KLS (Allbatross Portföy Katılım Serbest (Döviz) Fon) side by side.

SPK decided to liquidate HGH in bulletin 2026/60 dated September 17, 2026; no buy or redemption orders are executed in the fund. Its returns in this comparison are based on the last price published on TEFAS (September 29, 2026). HGH fund page · SPK bulletin 2026/60

HGHKLS
StockFund

If You Had Invested TRY 10,000

Metric Comparison

HGH vs KLS Fund Comparison
MetricHGHKLSCategory median
Daily−0.08%0.14%−0.07%
1 week−1.13%−0.68%−0.29%
1 month−3.45%−1.74%0.00%
3 months−9.23%0.05%4.33%
6 months5.91%−0.70%11.90%
YTD8.00%−2.35%14.97%
1 year−12.05%1.53%21.27%
3 years−31.08%—111.30%
Returns are based on prices as of September 29, 2026; the fund with the higher return or the lower risk score counts as the leader.

Popular Comparisons

Popular Fund Comparisons

Related Pages

About the HGH vs KLS Comparison

The price, returns, size and risk of HGH (Hedef Portföy Güneş Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) and KLS (Allbatross Portföy Katılım Serbest (Döviz) Fon) are compared side by side as of September 29, 2026. Of the 10 metrics compared, HGH leads in 4 and KLS leads in 6. HGH is a Hedge Fund fund managed by Hedef Portföy Yönetimi A.Ş.; KLS is a Hedge Fund fund managed by Allbatross Portföy Yönetimi Anonim Şirketi.

Highlights: Daily: KLS leads (0.14% vs −0.08%). 1 week: KLS leads (−0.68% vs −1.13%). 1 month: KLS leads (−1.74% vs −3.45%). 3 months: KLS leads (0.05% vs −9.23%). 6 months: HGH leads (5.91% vs −0.70%). YTD: HGH leads (8.00% vs −2.35%). 1 year: KLS leads (1.53% vs −12.05%). Size (TRY): HGH leads (988.3K vs 212K). Investors: HGH leads (19 vs 1). Risk: KLS leads (6 vs 7).

Frequently Asked Questions

Year to date HGH returned 8.00% and KLS returned −2.35%; over the last year HGH returned −12.05% and KLS returned 1.53%. Over the last month HGH returned −3.45% and KLS returned −1.74%. Past performance does not indicate future returns.

As of September 29, 2026, HGH has a size of TRY 988.3K with 19 investors, while KLS has a size of TRY 212K with 1 investors. HGH leads in size and HGH leads in investor count.

The CMB risk score of HGH is 7 out of 7 and that of KLS is 6. The risk score reflects the historical volatility of the fund price; 1 is the lowest and 7 the highest risk. A lower score means less volatility, not a guarantee of higher returns.